Congratulations Alligator Bioscience to SwedenBIO Award 2016!

The SwedenBIO Award has been presented for the tenth time. This year's winner is Alligator Bioscience AB. They are recognized for their combination of unique research and business acumen that has become a significant source of inspiration for many Swedish life science companies.

Jonas Esktrand, CEO SwedenBIO, Mårten Steen, Partner Healthcap, Per Norlén, CEO Alligator Bioscience and Lars Adlersson, Chairman SwedenBIO.

The justification reads:
Alligator Bioscience has been a true pioneer, identifying early on the potential for new therapeutic concepts to produce unique antibodies that have the potential to extend the lives of patients with metastatic cancer. The combination of high quality research and well-developed business acumen has resulted in an unprecedented collaboration agreement with one of the world’s largest pharmaceutical companies. Although the company is still in an early development phase and the project risk is therefore high, the commercial potential of the agreement serves as a significant source of inspiration for many Swedish life science companies.

Nominees
The nominees for the SwedenBIO Award 2016 were Alligator Bioscience AB, Aprea AB, CTC Clinical Trial Consultants AB, Dilafor AB, Moberg Pharma AB and Xbrane Biopharma AB.

Theprize
The prize is the industry’s own award and consists, in addition to the honor, of a traveling prize and two delegate places to the Nordic Life Science Days 14-15 September 2016
(www.nlsdays.com).

The award is given to a company that has demonstrated extraordinary achievements and success in the life science industry over the past year and has contributed to increased interest in the industry.

This year’s prize is the tenth of its kind and is awarded jointly with HealthCap. Previous winners include Recipharm, Orexo, Affibody, Vitrolife, Aerocrine, BioInvent, Cellavision, Medivir and Gyros.

The jury
The winner is chosen by the SwedenBIO board: Lars Adlersson, Six Year Plan, Ulrica Slåne, AP3, Sarah Fredriksson, Genovis, Jan Erneberg, GE Healthcare, Yvonne Mårtensson, independent board member and advisor, Per Samuelsson, HealthCap, Eva Sjökvist Saers, APL, Thomas Eldered, Recipharm, Magnus Björsne, AstraZeneca and Johan Brun, Pfizer.

Contact:
Lars Adlersson, Chairman of SwedenBIO, lars.adlersson@sixyearplan.se, 0706 666 236.